Corporate Overview
2023
TellBio is a development stage biotechnology company focused on revolutionizing the detection of cancer metastasis through its unique and proprietary circulating tumor cells (CTCs) technology, TellDx.
TellDx, the already fully functional diagnostic solution, detects and isolates live CTCs from patient liquid biopsies. The platform has been developed and optimized following a decade of R&D. TellDx offers a unique opportunity to detect CTCs via its microfluidic diagnostic platform to advance translational and clinical efforts and optimize the lives of patients with cancer.
TellBio is a development stage biotechnology company focused on revolutionizing the detection of cancer metastasis through its unique and proprietary circulating tumor cells (CTCs) technology, TellDx.
TellDx, the already fully functional diagnostic solution, detects and isolates live CTCs from patient liquid biopsies. The platform has been developed and optimized following a decade of R&D. TellDx offers a unique opportunity to detect CTCs via its microfluidic diagnostic platform to advance translational and clinical efforts and optimize the lives of patients with cancer.
